First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Sees Large Growth in Short Interest

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 500 shares, an increase of 66.7% from the September 15th total of 300 shares. Based on an average daily volume of 4,300 shares, the short-interest ratio is currently 0.1 days.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

A number of large investors have recently modified their holdings of FTXH. Janney Montgomery Scott LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the 1st quarter valued at $1,030,000. International Assets Investment Management LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter valued at approximately $73,000. Finally, Ameritas Investment Partners Inc. lifted its stake in First Trust Nasdaq Pharmaceuticals ETF by 5.5% during the 1st quarter. Ameritas Investment Partners Inc. now owns 11,200 shares of the company’s stock valued at $314,000 after acquiring an additional 587 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.0 %

Shares of NASDAQ FTXH traded up $0.01 during mid-day trading on Monday, reaching $28.67. 1,517 shares of the company were exchanged, compared to its average volume of 5,634. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $23.85 and a 1 year high of $29.72. The firm has a 50-day moving average of $28.86 and a 200 day moving average of $27.75. The stock has a market cap of $17.20 million, a price-to-earnings ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Thursday, September 26th were given a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a yield of 1.70%. The ex-dividend date was Thursday, September 26th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.